The pretreatment with A. muciniphila alleviated the phenotype of DSS-induced colitis mice through activating NLRP3 and decreasing the expression of pro-inflammatory cytokines (IL1β, IL-6) and chemokines MCP-1. The gene discussed is IL1B; the disease is colitis.